Local time Wednesday, the three major U.S. stock indexes closed down, the Dow fell 1.02%, has fallen for five consecutive trading days; The Nasdaq fell 3.18% and the S&P 500 fell 1.65%.
Technology stocks led the way lower, with Tesla falling more than 8% and Apple closing down 5.18%. Apple also ceded the title of "world's most valuable" to oil company Saudi Aramco.
Technology stocks led the decline, with Apple down more than 5%, Microsoft down more than 3%, Tesla down more than 8% and Facebook down more than 4%.
ACCORDING TO DATA RELEASED BY THE US DEPARTMENT OF LABOUR ON THE SAME DAY, the US consumer price index (CPI) rose 0.3% month-on-month and 8.3% year-on-year in April. While year-on-year CPI growth eased slightly in April from 8.5 per cent in March, it remained historically high, indicating persistent inflationary pressures. The stock market's recent pullback has intensified fears that the Federal Reserve's aggressive efforts to raise interest rates to fight inflation could trigger a recession.
U.S. food prices rose 9.4% over the past 12 months, the highest since April 1981. Over the same period, energy prices rose 30.3 per cent, used and new car prices rose 22.7 per cent and 13.2 per cent respectively, and airfares rose 33.2 per cent, the biggest year-on-year increase since December 1980.
Sarah House, an economist at Wells Fargo, said the fall in year-on-year CPI growth marked "the beginning" of inflation returning to the Fed's target. However, with core CPI still more than three times above the Fed's 2 per cent target, inflation "still has a long way to go".
At a press conference after the Fed raised its benchmark interest rate by half a percentage point last week, Fed Chairman Jerome Powell acknowledged that inflation was too high and that the Fed needed to lower it to keep the labour market strong. Mr Powell said the FOMC thought a 50 basis point increase was possible at the next few meetings but was not considering a single 75 basis point increase.
U.S. President Joe Biden said that while it is encouraging to hear that annual inflation slowed in April, the fact remains that inflation remains "unacceptably high" and that bringing it down is his top economic priority.
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables. Send an email to: email@example.com and our professional sales engineer will get back to you within 48 hours.
Overview of market area prospect of polymerase chain reaction test
By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America is further divided into countries such as the United States and Canada. The European region is further divided into The United Kingdom, France, Germany, Italy, Spain, Russia and the rest of Europe. The Asia Pacific region is further subdivided into China, Japan, Korea, India, Australia, Southeast Asia and the rest of Asia Pacific. The Latin America region is further subdivided into Brazil, Mexico and the rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa and the rest of MEA.
Market Demand of the polymerase chain reaction test
The DNA/RNA Extraction Kit market and other polymerase chain reaction tests are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the polymerase chain reaction test market for a short time due to restrictions on different business and research activities for polymerase chain reaction tests. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for the polymerase chain reaction test
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global polymerase chain reaction test market during the forecast period
North America, which holds a major share in the polymerase chain reaction test market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for polymerase chain reaction tests, and the rising prevalence of chronic diseases.
The polymerase chain reaction test professional supplier-Geneture
Geneture is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier. Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
Local time Wednesday, the three major U.S. stock indexes closed down, the Dow fell 1.02%, has fallen for five consecutive trading days; The Nasdaq fell 3.18% and the S&P 500 fell 1.65%. Techn…
Gold is a high-quality hedge hedging tool, favored by investors. Especially in recent years, with the increasing instability of the world economy, gold has become one of the preferred asset allocations of investors because of its functions of hedging…
TR30 foam generator developed by our company. It can be used in laboratories, small-scale foam concrete cast-in-situ projects, and pilot lines of foam concrete products. The outstanding advantages of TR30 foam generator are low foam moisture content,…